Veritas Farms (VFRM) Stock: Sales Likely To Rise After GQ Recommendation

Veritas Farms (NASDAQ: VFRM) is a stock that I’ve been watching incredibly closely. There are several reasons that I maintain a bullish view on the stock. Nonetheless, the opportunity just got bigger.

The company’s products were mentioned in a GQ article that has the potential to greatly improve sales. Today, we’ll talk about:

  • The GQ article;
  • why I believe that VFRM is a key stock to watch in the CBD space; and
  • what we’ll be watching for ahead.

VFRM Sales Could Run For The Top After GQ Mention

As mentioned above, Veritas Farms is a stock that I’ve been watching for some time. So far, I’ve followed the stock from $0.49 in late February to $0.80 today. However, I believe that the growth is far from over, and thanks to a recent GQ article, we could see another run in value relatively soon.

In the GQ article, the author, Alex Shultz outlined the best CBD products to try if you don’t want to get high on 4/20. The list featured some heavy hitter brands, including Veritas Farms.

In fact, the company’s CBD gummies made it to #3 on the list. Considering that GQ has a massive audience, VFRM will likely see yet another increase in sales as major media continues to pick up the company’s offering in a positive light.

Why This Stock Could Be A Strong Long-Run Play In CBD

At the end of the day, there are several reasons to be excited about VFRM. First and foremost, the company handles the entire process from seed to sale with no middle man. Moreover, it is already located in the United States, where high-value Canadian cannabis producers are working hard and spending massive amounts of money to make an entrance.

Moreover, Veritas Farms seems to have a marketing strategy that is second to none and is working overwhelmingly well. Ultimately, the company is working to expand its retail footprint as the CBD market is emerging, and it is doing so with incredible success. In fact, the company recently mentioned that its products are being sold in select CVS Pharmacy stores.

I recently wrote a full report on VFRM. If you’re interested in digging further into the company, click here.

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on VFRM. In particular, we’re interested in following the story surrounding the company’s continued work to expand its retail footprint as well as the company’s coverage among major media outlets, as this continued positive coverage will likely lead to increased sales. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!
* indicates required

Leave a Comment